Eptifibatide-peptides, a highly regarded Platelet Aggregation Inhibitor & RGD Mimetic, plays a significant role in biomedical research, drug discovery and development. Features include:
Samples are available for evaluation purposes.
Eptifibatide, commonly known as Integrilin, is touted as an innovative chemical compound notable for its powerful inhibitory effects against platelet aggregation. Cloaked in the exquisite design of cyclic heptapeptide, it is highly valued in biomedical science and pharmaceutical industries. Capitalize on the highest quality Eptifibatide, masterfully synthesized in state-of-the-art facilities, for guaranteed superior performance.
Eptifibatide executes its action as an RGD (Arginine-Glycine-Aspartate) mimetic, mimicking the function of the tripeptide crucial for cell adhesion. Its action mechanism fundamentally interferes with platelet aggregation, blocking the binding of fibrinogen, von Willebrand factor, and other pivotal adhesion molecules. This makes Eptifibatide highly reliable and effective in its dedicated role.
Consistent with impeccable standard and credibility, Eptifibatide's functionality and all-encompassing applicability can be availed after comprehensive testing and evaluation, keeping your confidence in its unmatched efficiency built and fostered throughout.
Eptifibatide is transformative to your organization and a catalyst for research boundaries, redefining the horizons of control over platelet aggregation.